CutressML, StewartGD, Wells-ColeS, et al.Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int, 2012; 110:1608–1617.
2.
GrassoM, FishmanAI, CohenJ, AlexanderB. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: A 15-year comprehensive review of 160 consecutive patients. BJU Int, 2012; 110:1618–1626.
3.
RouprêtM, BabjukM, CompératE, et al.European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol, 2015. Epub ahead of print.
4.
BusMT, de BruinDM, FaberDJ, et al.Optical diagnostics for upper urinary tract urothelial cancer: Technology, thresholds, and clinical applications. J Endourol, 2015; 29:113–123.
5.
HendersonJM, FowlerS, JoyceA, et al; BAUS. Perioperative outcomes of 6042 nephrectomies in 2012: Surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database. BJU Int, 2015; 115:121–126.
6.
GrollmanAP. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Environ Mol Mutagen, 2013; 54:1–7.